DaVita Inc. (DVA) Stock Price & AI Analysis

NYSE
USA

$169.97

$3.72
(2.24%)

Subscribe to get
AI Score

DaVita Inc. Company Profile

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc. | Latest news

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....

Zacks - 3 days ago

Is DaVita Inc. (DVA) the Cheap Value Stock to Invest in According to Warren...

We recently published a list of 10 Cheap Value Stocks to Invest in According to Warren Buffett. In...

Insider Monkey - 7 days ago

Assenagon Asset Management S.A. Has $11.16 Million Position in DaVita Inc....

Assenagon Asset Management S.A. boosted its holdings in shares of DaVita Inc. (NYSE:DVA – Free Report) by 201.7% in the 4th quarter, according to the company in its most recent 13F filing with ...

ETF DAILY NEWS - 5 days ago

DaVita HealthCare (DVA) Gains But Lags Market: What You Should Know

DaVita HealthCare (DVA) closed the most recent trading day at $166.24, moving +0.84% from the...

Zacks - 6 days ago

DVA: Raising target price to $178.00

DAVITA INC has an Investment Rating of HOLD; a target price of $178.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength ...

Argus Research - 2 days ago

Burney Co. Sells 268 Shares of DaVita Inc. (NYSE:DVA)

Burney Co. reduced its stake in DaVita Inc. (NYSE:DVA – Free Report) by 16.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,391 ...

ETF DAILY NEWS - 5 days ago

Analysts Set DaVita Inc. (NYSE:DVA) Price Target at $161.80

DaVita Inc. (NYSE:DVA – Get Free Report) has been assigned an average recommendation of “Hold” from the five analysts that are currently covering the stock, Marketbeat reports. One analyst has ...

ETF DAILY NEWS - 4 days ago

Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus...

Release Chicago, IL – January 17, 2025 – Today, Zacks Equity Research Equity Quest Diagnostics Inc....

Zacks - 7 days ago

Masimo Stock Gains Following Solid Preliminary Q4 Revenues

A few other top-ranked stocks in the broader medical space are Cardinal Health, Inc. CAH, Cencora,...

Zacks - 3 days ago